Laboratory Corp. of America Holdings (NYSE: LH) reported earnings on Feb. 10. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Laboratory Corp. of America Holdings met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share improved.

Margins dropped across the board.

Revenue details
Laboratory Corp. of America Holdings reported revenue of $1.37 billion. The 21 analysts polled by S&P Capital IQ predicted a top line of $1.38 billion on the same basis. GAAP reported sales were 5.5% higher than the prior-year quarter's $1.30 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $1.43. The 15 earnings estimates compiled by S&P Capital IQ predicted $1.40 per share on the same basis. GAAP EPS of $1.34 for Q4 were 7.2% higher than the prior-year quarter's $1.25 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 40.2%, 70 basis points worse than the prior-year quarter. Operating margin was 18.9%, 60 basis points worse than the prior-year quarter. Net margin was 9.9%, 30 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $1.41 billion. On the bottom line, the average EPS estimate is $1.57.

Next year's average estimate for revenue is $5.73 billion. The average EPS estimate is $6.52.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 684 members out of 702 rating the stock outperform, and 19 members rating it underperform. Among 240 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 238 give Laboratory Corp. of America Holdings a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Laboratory Corp. of America Holdings is hold, with an average price target of $93.23.

If you're interested in health care stocks like Laboratory Corp. of America Holdings, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.